Filter By
SUHAGRA 100 is a powerful erectile dysfunction (ED) treatment containing 100mg of Sildenafil Citrate, available in a 4-tablet retail pack.Manufactured under WHO-GMP standards and exported globally by BLUEPILL...
SILAGRA 100 contains Sildenafil Citrate 100mg, the gold-standard treatment for erectile dysfunction (ED). This pack includes 4 oral tablets, manufactured under WHO-GMP and FDA-compliant standards, and exported globally...
CENFORCE-D** is a dual-action tablet combining Sildenafil Citrate 100mg and Dapoxetine 60mg to treat erectile dysfunction (ED) and premature ejaculation (PE) simultaneously. It offers improved stamina, stronger erections,...
CENFORCE SOFT 100 is a chewable Sildenafil Citrate tablet (100mg) designed for men seeking fast-acting relief from erectile dysfunction (ED). Its soft formulation allows for rapid absorption and...
CENFORCE PROFESSIONAL 100mg** is a sublingual tablet containing Sildenafil Citrate 100mg, offering fast-acting relief from erectile dysfunction (ED). Designed for quick absorption under the tongue, it provides enhanced...
CENFORCE FM is a specialty formulation containing Sildenafil Citrate 100mg, designed specifically for female sexual arousal disorder (FSAD). It enhances blood flow and sensitivity in the genital region,...
CENFORCE 50** contains 50mg of Sildenafil Citrate, a balanced and effective dose for treating erectile dysfunction (ED). It is commonly recommended as the initial dose for most men...
CENFORCE 25 contains 25mg of Sildenafil Citrate, making it the lowest strength dosage for erectile dysfunction (ED) treatment. Ideal for beginners or men with mild ED, it provides...
CENFORCE 200** is an ultra-strength oral treatment for erectile dysfunction (ED) containing 200mg of Sildenafil Citrate. It is specifically formulated for men with severe ED or resistance to...
CENFORCE 150 is a maximum-strength erectile dysfunction (ED) treatment containing 150mg of Sildenafil Citrate. It is ideal for men who require a higher dosage to achieve strong, long-lasting...
